Uranyl Acetate Structure

International Bio-Analytical Industries, Inc.

Uranium Tri Oxide Structure

 

www.ibilabs.com

 

BACK TO MSDS MAIN

  Uranyl Fluoride MSDS

UO2F2

 

CAS #

Formula

Formula Weight

13536-84-0

UO2F2

308.00

Color Crystalline Form

Specific Gravity

Melting Point

Boiling Point

 

 

 

 

Solubility in 100 parts

Cold Water

Hot Water

Other Reagents

 

 

 

 
 

Uranyl fluoride

  • Uranium fluoride oxide
  • Uranium oxyfluoride
  • Difluorodioxouranium
  • Uranyldifluoride
Formula (UO2)F2
Structure
Description Pale yellow, rhombohedral, hygroscopic.
Uses An intermediate in the conversion of uranium hexafluoride uf6 to an uranium oxide or metal form.
Registry Numbers and Inventories.
CAS 13536-84-0
NIH PubChem CID 26096
EC (EINECS/ELINCS) 236-898-8
RTECS YR4700000
RTECS class Mutagen
Beilstein/Gmelin 39910 (G)
Canada DSL/NDSL NDSL
US TSCA Listed
Properties.
Formula F2O2U
Formula mass 308
Decomposition point, °C 300
Density 6.45 g/cm3
Solubility in water very soluble
Hazards and Protection.
Storage Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
Handling All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Protection Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Respirators Escape; Respirator class(es): any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted acid gas canister having a high-efficiency particulate filter. Any appropriate escape-type, self-contained breathing apparatus.
Small spills/leaks Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Stability No data.
Incompatibilities Strong oxidizing agents.
Fire.
Fire fighting Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Health.
Exposure limit(s) OSHA: PEL (8 h TWA): 2.5 mg/m3.
Exposure effects Hyperactive reflexes, painful muscle spasms, weakness and tetanic contractures may be noted due to fluoride induced hypocalcemia. Prenatal fluoride supplementation (2.2 mg NaF or 1 mg fluoride daily) during the last two trimesters of pregnancy has been reported to be safe.
Ingestion Epigastric pain, nausea, dysphagia, salivation, hematemesis, and diarrhea may be noted. These effects may be delayed for several hours following exposure. Gi symptoms are noted when 3 to 5 mg/kg of fluoride are ingested.
Inhalation Respirations are first stimulated then depressed. Death is usually from respiratory paralysis. Following inhalation, coughing and choking may be noted.
Skin Urticaria and pruritus have been reported following exposure to fluoride.

First aid
 
Ingestion Administer milk, calcium gluconate, or calcium lactate to bind fluoride ion in the gastrointestinal tract. Antacids (aluminum and/or magnesium based) should be administered. Iv calcium (gluconate or chloride) and magnesium may be necessary to correct serum deficits of these divalent metals in serious overdosage. Monitor ekg and vital signs.
Inhalation Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.
Skin Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician should examine the area if irritation or pain persists.
Eyes Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.
Transportation

 

 

  

 
 
Your Name:
Your Job/Discipline:

                 

Employer/Work Location:
Country:
Your Email Address:
Your Phone Number:
Requested Information:
 
Please fill out the above form and click the submit button:     

 

                                        
 

 
or: email us at contact@ibilabs.com